Coming Off GLP-1: Maintenance, Reverse Titration & Avoiding Rebound

The data is clear: stop a GLP-1 cold and most people regain about two-thirds of the weight within a year. The good news in 2026 is that two strategies — maintenance dosing and proper reverse titration — change that trajectory significantly.

Why the rebound happens

GLP-1 agonists work on appetite signaling, gastric emptying, and reward pathways. Stop the drug and:

1. Hunger and food noise return within days
2. Gastric emptying speeds back up — bigger meals feel normal again
3. Setpoint biology pushes back — your body actively defends a higher fat mass
4. Years of food habits don't change overnight

This isn't a willpower failure. It's pharmacology meeting biology.

Strategy 1: Stay on a maintenance dose (most patients)

For most people who tolerate GLP-1 well, the current best-practice answer is don't fully stop. Stay on a lower dose long-term:

Many patients find that the lowest dose that holds their weight is much lower than their peak dose. That's a meaningful cost reduction too. Document your weight weekly during the search.

Strategy 2: Reverse titration (true exit)

If you genuinely want off the drug — for cost, family planning, side effects, or just preference — do it the same way you got on: slowly.

A reasonable reverse-titration schedule for Wegovy:

And for Zepbound:

A 16-week wean is far more sustainable than a cliff stop. Hunger returns gradually instead of overnight; you have time to rebuild habits.

The behavioral side (the part that actually keeps weight off)

Drug + behavior > drug alone, and behavior > drug once you're off. The strongest data:

• Resistance training 2–4×/week — preserves lean mass during loss and after stop. This is the single best predictor of staying off.
• Protein floor: 1.2–1.6 g/kg target body weight
• Daily step count > 7,500
• Weekly weigh-ins — early warning if regain starts
• Sleep ≥ 7 hours — short sleep raises hunger hormones aggressively
• Alcohol audit — alcohol returns appetite faster than almost anything

The patients who maintain are the ones who treat the drug as a window, not a destination.

Side-effect changes when tapering

Going down can produce mirror-image side effects of going up:

• Hunger rebound within 1–2 weeks of each step down — expected, not failure
• Faster gastric emptying — you may feel hungrier sooner after meals
• Cravings, especially sweet/salty — common in week 1 of a step
• Mood dips — some patients report transient low mood as reward signaling normalizes; usually resolves in 2–4 weeks

If hunger overwhelms you at a step, hold longer rather than restarting from zero.

When to restart

If you've fully stopped and regain accelerates:

• Restart at your previous lowest effective dose, not the starter
• Re-engage with a clinician — don't self-titrate from leftover pens
• This is not failure; it's chronic-disease management

Obesity behaves like other chronic conditions. Hypertension medications are taken long-term too. Reframing the question from "How fast can I stop?" to "What's my smallest effective dose?" tends to produce better outcomes.

Talk to a clinician about your taper plan

Don't design a wean by yourself, and don't trust a clinic that won't discuss the exit. Find a clinic that supports maintenance and tapering →

General information, not medical advice. Maintenance and taper decisions are individual and should involve your prescribing clinician.